Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Operating Expenses (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Operating Expenses data on record, last reported at $82.5 million in Q4 2025.

  • For Q4 2025, Operating Expenses fell 3.09% year-over-year to $82.5 million; the TTM value through Dec 2025 reached $298.6 million, up 5.61%, while the annual FY2025 figure was $291.2 million, 11.96% up from the prior year.
  • Operating Expenses reached $82.5 million in Q4 2025 per PAHC's latest filing, up from $68.8 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $85.2 million in Q4 2024 and bottomed at $48.4 million in Q4 2021.
  • Average Operating Expenses over 5 years is $62.3 million, with a median of $60.6 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: fell 4.75% in 2023, then surged 35.34% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $48.4 million in 2021, then rose by 27.21% to $61.5 million in 2022, then rose by 2.23% to $62.9 million in 2023, then soared by 35.34% to $85.2 million in 2024, then dropped by 3.09% to $82.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $82.5 million in Q4 2025, $68.8 million in Q3 2025, and $76.3 million in Q2 2025.